About Growmore Bio-Tech Limited
Data last updated: 21 December 2025
Growmore Bio-Tech Limited is a public limited company based in Tamilnadu, Tamil Nadu, India. It specialises in agricultural support and advisory, a part of the broader agriculture sector. Incorporated on 10 July 1995, the company has been in operation for over 31 years.
Registered with ROC Chennai under CIN U01119TN1995PLC032185.
Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Shanti Jetty and Shalini Jetty.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: 43 Main Road Kovilpatti – 627 701. Tamilnadu, Tamil Nadu, India – 627701.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.45 Cr, a growth of 6% compared to the previous year.
The company has a workforce of approximately 61 employees as per the latest available data.
The company is associated with 1 brand - Growmore Biotech. As per MCA filings, the company has open charges of ₹30 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website growmorebiotech.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address43 Main Road Kovilpatti – 627 701. Tamilnadu, Tamil Nadu, India – 627701
-
IndustryAgriculture, Agri Support Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Growmore Bio-Tech Limited
Growmore Bio-Tech Limited operates one associated brand: Growmore Biotech. These brands represent Growmore Bio-Tech Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides high-quality plants, focuses on bamboo cultivation and international export. | growmorebiotech.com |
Competitors & Alternatives of Growmore Bio-Tech Limited
Brands and companies operating in the same space as Growmore Bio-Tech Limited include Sutro Biopharma, Synthego, Avidity Biosciences and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Sutro Biopharma
|
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | United States | 2003 |
Synthego
|
CRISPR-engineered cell and gene therapies are developed for research applications. | Redwood City, United States, United States | 2012 |
Avidity Biosciences
|
Antibody-siRNA complexes are developed for cancer treatment. | San Diego, United States, United States | 2012 |
Antheia
|
Yeast cells are genetically engineered to produce medicinal products. | Palo Alto, United States, United States | 2013 |
Vividion Therapeutics
|
Developing novel drugs based on a proteome-wide ligand and target discovery platform | Oceanside, United States, United States | 2016 |
Korro Bio
|
RNA-editing technologies are provided for precision medicine applications. | Cambridge, United States, United States | 2018 |
Straumann Group
|
Dental implants and regenerative dentistry products are developed. | Basel, Switzerland, Switzerland | 1954 |
Judges Scientific
|
Acquisition and development of scientific instrument businesses is conducted. | London, United Kingdom, United Kingdom | 2002 |
Savara Pharma
|
Therapeutics for rare respiratory diseases are developed by Savara Pharma. | Austin, United States, United States | 2008 |
Univercells
|
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | Charleroi, Belgium, Belgium | 2013 |
Business Activity of Growmore Bio-Tech Limited
Growmore Bio-Tech Limited is engaged in the principal business activity of agriculture, forestry, fishing, with detailed activities including production of crops and animals.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| A | Agriculture, forestry, fishing | A1 | Production of crops and animals | ********* |
Auditor Details of Growmore Bio-Tech Limited
Growmore Bio-Tech Limited is audited by S.LAKSHMANAPERUMAL for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.LAKSHMANAPERUMAL | blur-value | blur-value | blur-value |
Board of Directors of Growmore Bio-Tech Limited
Growmore Bio-Tech Limited is currently managed by 7 directors, with 5 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shanti Jetty | Director | 01 Nov 2009 | 16 Years 8 Months | Current |
| Shalini Jetty | Director | 19 Mar 2020 | 6 Years 3 Months | Current |
|
Srinivas Sai Prasad
Also directs:
Qre Greenesol Power Transformer Company Private Limited
|
Director | 19 Mar 2020 | 6 Years 3 Months | Current |
|
Sivaram Prasad Jetty
Also directs:
Keerthi Industries Limited, Hmg Power Systems Private Limited, Greenesol Power Systems Private Limited and 5 more
|
Director | 26 Feb 2009 | 17 Years 4 Months | Current |
|
Padmavathy Shridhar
Also directs:
Qre Greenesol Power Transformer Company Private Limited
|
Director | 01 Nov 2009 | 16 Years 8 Months | Current |
| Nambhi Barathi | Director | 10 Jul 1995 | 30 Years 11 Months | Current |
Financials of Growmore Bio-Tech Limited FY 2024 filings available
Growmore Bio-Tech Limited reported revenue of ₹6.45 Cr (up 6% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Growmore Bio-Tech Limited
As of FY 2023, Growmore Bio-Tech Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Growmore Bio-Tech Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2000 | State Bank of India | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Growmore Bio-Tech Limited
Growmore Bio-Tech Limited has a workforce of 61 employees as of Apr 09, 2024.
Employee Count & EPFO Data of Growmore Bio-Tech Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Growmore Bio-Tech Limited
GSTIN & GST Filing Data of Growmore Bio-Tech Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Growmore Bio-Tech Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Growmore Bio-Tech Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Growmore Bio-Tech Limited
MSME Payment Delays by Growmore Bio-Tech Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Growmore Bio-Tech Limited
Subsidiaries & Group Companies of Growmore Bio-Tech Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Growmore Bio-Tech Limited with ownership details.
MCA Filings & Documents of Growmore Bio-Tech Limited
MCA Filings & Documents of Growmore Bio-Tech Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Growmore Bio-Tech Limited
Frequently Asked Questions about Growmore Bio-Tech Limited
Growmore Bio-Tech Limited is an active public limited company in the agriculture sector based in Tamilnadu, Tamil Nadu, India. It was incorporated on 10 July 1995 (31+ years old) and is registered under CIN U01119TN1995PLC032185. The company has 61 employees.
Growmore Bio-Tech Limited reported revenue of ₹6.45 Cr for FY 2025 (up 6.00% YoY).
The current directors of Growmore Bio-Tech Limited are:
The primary industry of Growmore Bio-Tech Limited is agriculture. The company specifically operates in agri support services. The company is currently active in this sector.
Growmore Bio-Tech Limited can be reached at the registered office: 43 Main Road Kovilpatti – 627 701. Tamilnadu, Tamil Nadu, India – 627701, or through the website growmorebiotech.com.
The authorised capital is ₹2 Cr, and the paid-up capital is ₹2 Cr.